#ALTY Orthopaedic Hospital

[kazifatagar]

ALTY Orthopaedic Hospital and MHTC To Promote Malaysia As Preferred Orthopaedic Healthcare Destination

ALTY Orthopaedic Hospital and Malaysia Healthcare Travel Council (MHTC) have partnered to promote Malaysia as a top destination for orthopaedic medical tourism. To celebrate their collaboration, they are offering free posture screenings to arriving tourists at Kuala Lumpur International Airport (KLIA) during International Scoliosis Awareness Month. Additionally, they aim to highlight MHTC’s…

[healthcaremarketanalysis]

Orthopedic Devices Industry worth $48.1 billion by 2028, with a CAGR of 4.8%

The report “Orthopedic Devices Market by Product (Fixation, Replacement Devices {knee, Hip, Shoulder}, Braces, Spinal Implants, Arthroscopy, Orthobiolgics), Application (Fracture Treatment, Osteoarthritis), End User (Hospital, ASCs)- Global Forecast to 2028” is projected to reach USD 48.1 billion by 2028 from USD 36.3 billion in 2022, at a CAGR of 4.8% during the forecast period. Growth in elderly population worldwide, increasing number of osteoarthritis cases, growing participation in sports, rising awareness about the presence of orthopedic treatment, technological advancements and growth strategies adopted by the players in the orthopedic devices such as product launches, agreements, partnerships, and acquisitions are expected to propel the growth of the market.

Browse 278 market data Tables and 41 Figures spread through 386 Pages and in-depth TOC on “Orthopedic Devices Market — Global Forecast to 2028” View detailed Table of Content here — https://www.marketsandmarkets.com/Market-Reports/orthopedic-device-280.html

The orthopedic devices market includes major Tier I and II suppliers of orthopedic products are Stryker Corporation (US), Johnson & Johnson (US), Smith & Nephew (UK), Medtronic plc (Ireland), Zimmer Biomet (US), B. Braun (Germany), Enovis (US), NuVasive (US), Acumed LLC (US), BSN Medical (Germany), CONMED Corporation (US), Orthofix Medical Inc. (US), Arthrex (US), Allegra Orthopaedics (Australia), DeRoyal Industries (US), MicroPort (China), Nippon Sigmax Co., Ltd. (Japan), TriMed Inc. (US), Altis Biologics (South Africa), Isto Biologics (US), ITS (Austria), Meril Life Sciences Pvt. Ltd. (India), Mueller Sports Medicine, Inc. (US), RCH Orthopaedics (India), and FLA Orthopedics (US).

Increasing aging population with degenerative spine diseases are anticipated to accelerate the demand for spinal implants and surgical devices

The incidence of degenerative lumbar spine disease is currently increasing among older generation and this has led to an increased demand for spinal surgeries. Acceptance of minimally invasive procedures in treatment of spinal cord disorders involve lesser muscle damage, blood loss, shorter hospital stays; quicker recovery; and preservation of spinal mobility post-surgery are contributing towards the growth of the segment. Moreover, rising cases of road accidents and sports related spinal injuries and growing advancements in spinal implants are anticipated to enhance the growth of segment.

Orthopedic devices market is anticipated to grow at the fastest pace in Asia Pacific

The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028. The presence of a large patient population, improved healthcare infrastructure, the rising number of hospitals, and the rapidly growing aging population (especially in Japan and China) are likely to contribute towards the rapid growth of orthopedic devices market in Asia Pacific Additionally, grants offered by the government to promote the awareness and research on orthopedic diseases, expansion of geographical footprints of key players in Asian Countries by setting up orthopedic devices manufacturing units and increasing local manufacturers in the region are anticipated to support the significant growth orthopedic devices market in Asia Pacific.

Prominent players in this market are Stryker Corporation (US), Johnson & Johnson (US), Smith & Nephew (UK), Medtronic plc (Ireland), Zimmer Biomet (US), B. Braun (Germany), Enovis (US), NuVasive (US), Acumed LLC (US), BSN Medical (Germany), CONMED Corporation (US), Orthofix Medical Inc. (US), Arthrex (US), Allegra Orthopaedics (Australia), DeRoyal Industries (US), among others

Recent Developments of the Orthopedic Devices Market

In January 2023, Zimmer Biomet acquired Embody, Inc. with a focus on strengthening its brand presence in the orthopedic devices market.

In November 2022, Enovis announced the launch of a new DynaNail Helix fixation system used for the treatment of bone fractures, joint fusion, and bone reconstruction.

In September 2022, Stryker Corporation introduced New Gamma4 Hip fracture nailing system to expand its orthopedic fixation devices product portfolio.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America���s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies — helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1–888–600–6441

UK +44–800–368–9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

[dailystraitsdotcom]

Risks Of Osteoporosis

Understanding And Preventing The Risks Of Osteoporosis In Women Aged 40 And Above by Dr. Mark Chong, Consultant Trauma and Orthopaedic Surgeon at ALTY Orthopaedic Hospital. #Health #Columnist

Follow us on LinkedIn, Instagram, Facebook, YouTube and Twitter By Dr Mark ChongTweet Menopause is the natural biological process women go through that marks the end of their reproductive years in the 40s and 50s.The process is gradual and causes significant hormonal changes, resulting in many unique symptoms such as hot flashes, mood swings, sleep deprivation, moodiness and…

[thewellnessinsider]

How Southeast Asian Healthcare Providers Resolve Cost Pressures

How Southeast Asian Healthcare Providers Resolve Cost Pressures

Spending on healthcare in Southeast Asia is rising amidst inflation and the prevalence of non-communicable diseases. The 2020 INSEAD study showed that the region’s healthcare expenditure will grow to US$740b by 2025. Hospitals are coping with this by investing in single-specialty hospitals. TE Asia Healthcare Partners, for instance, established the ALTY Orthopaedic Hospital in Malaysia, which…

[meticulousresearch-blog]

Bone Growth Stimulator Market

The Global Bone Growth Stimulator Market will grow at a CAGR of 5.8% during the forecast period to reach USD 1,397.6 million by 2022, according to the latest publication from Meticulous Research®. The bone growth stimulator market driven by growing geriatric population with the prevalence of orthopaedic issues and rising preference for stimulation treatments. Moreover, emerging economies such as Latin America, Asia, and Africa provides significant opportunities in this market. However, complications associated with the use of bone morphogenetic proteins (BMP) and unfavorable reimbursement scenario related to bone growth stimulators hinders the growth of the market to some extent.

The global bone growth stimulator market is mainly segmented by product, (bone growth stimulation devices, bone morphogenetic proteins, and platelet rich plasma), by application, (spinal fusion surgeries, delayed union & non-union fractures, oral and maxillofacial surgeries, and others), by end user (hospitals & clinics, academic and research institutes, contract research organizations, and home care), and geography.

Browse in-depth Report on: //www.meticulousresearch.com/product/bone-growth-stimulator-market-2022/

Based on product type, bone growth stimulation devices held the largest share of the market in 2016 and expected to continue its dominance in the global bone growth stimulator market during the forecast period, owing to rising adoption of external & implanted stimulators for the accurate treatment therapy with increasing incidence & prevalence of orthopedic problems with aging population, growing need for cost effective & easy accessible medical devices, rising number of road accidents & trauma, reducing complications associated with bone surgeries, and increasing secondary diseased conditions such as obesity & diabetes.

On the basis of application, spinal fusion surgeries held the largest share in the global bone growth stimulator market in 2016. This was mainly attributed to rising number of spine procedures with increasing risk of orthopedic problems, increasing bone related injuries by growing number of road accidents, trauma and sport activities, growing pain from degenerative disc disorder with instability, and rising adoption of bone growth stimulation products due to decreasing normal bone healing process with increase in the age.

Request-Sample-Report:https://www.meticulousresearch.com/request-sample-report/?cp_id=3530

Based on end user, hospitals & clinics commanded the largest share in 2016 due to continuous increase in the number of spinal fusion and orthopedic surgeries performed in the hospital settings, and related increase in the demand for bone growth stimulators from these healthcare organizations to enhance the bone healing process of their patients.

Geographically, this market is segmented into North America (U.S. and Canada), Europe (Germany, France, Italy, Spain, U.K., Turkey, and RoE), Asia Pacific (China, India, Japan, Indonesia, South Korea, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share in the global bone growth stimulator market in 2016, followed by Europe and Asia-Pacific. The large share of this market is mainly attributed to remarkably advanced healthcare industry with higher healthcare spending and adoption of innovative science & technology; increasing prevalence & incidence of orthopedic diseases such as osteoarthritis, chronic back & neck pain, rheumatoid arthritis, and others with expanding proportion of elderly population; availability of research funding; and growing focus on improving treatments. However, Asia Pacific and Latin America regions are expected to witness significant growth during the forecast period due to demographic transition from high fertility & mortality to low fertility & mortality, accelerated growth of economies, lower regulatory hurdles, remarkable advances in science & technology; increasing incidence of fractures, osteoporosis, and spinal diseases with aging population; growing patient awareness regarding stimulation treatments; and increasing demand for less invasive therapies in the region.

Speak-To-Analyst: https://www.meticulousresearch.com/speak-to-analyst/?cp_id=3530

Global Bone Growth Stimulator Market Size, by Geography, 2017- 2022

The key players in the global bone growth stimulator market are Orthofix International N.V. (U.S.), DJO Global, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Johnson & Johnson (U.S.), Stryker Corporation (U.S.), Bioventus Inc. (U.S.), Arthrex, Inc. (U.S.), ISTO Biologics (U.S.), Ossatec Benelux Ltd. (Netherland), Regen Lab SA (Switzerland), ITO CO., Ltd. (Japan), Altis Biologics (Pty) Ltd (South Africa), and Harvest Technologies Corporation (U.S.).

Download-Sample-Report:https://www.meticulousresearch.com/download-sample-report/?cp_id=3530

About Meticulous Research®

Meticulous Research® is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact Us: Viren Shrivastava

AVP- Global Sales and Marketing

Meticulous Research®

Tel: +1-646-781-8004

Email: viren@meticulousresearch.com

[dailystraitsdotcom]

How is Malaysia Positioned to Become a Leading Hub for Orthopaedic Treatments in APAC By DrDr G Ruslan Nazaruddin Simanjuntak, a Consultant Orthopaedic from ALTY Orthopaedic Hospital. #Columnist #Malaysia #HealthNews Read the full story here: https://dailystraits.com/2022/04/01/positioning-malaysia-favourably/ (at Kuala Lumpur, Malaysia) https://www.instagram.com/p/CbzsBnyh0HN/?utm_medium=tumblr

[dailystraitsdotcom]

Positioning Malaysia Favourably

How is Malaysia Positioned to Become a Leading Hub for Orthopaedic Treatments in APAC By DrDr G Ruslan Nazaruddin Simanjuntak, a Consultant Orthopaedic from ALTY Orthopaedic Hospital. #Columnist #Malaysia #HealthNews

Follow us on LinkedIn, Instagram, Facebook, YouTube and Twitter By Dr G Ruslan Nazaruddin Simanjuntak With the reopening of Malaysian borders, we are sure to see several sectors such as tourism, hospitality and aviation work toward their recovery phase. One such sector that promises recovery and growth for the national economy on the reopening of borders is healthcare travel. In 2019, Malaysia…